These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1446971)

  • 21. Structural requirements of the oxytocin receptor in rat uterus. Free-Wilson analysis in a series of competitive oxytocin inhibitors.
    Pliska V; Heiniger J
    Int J Pept Protein Res; 1988 Jun; 31(6):520-36. PubMed ID: 2842268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [4-(0-methyl)-L-threonine] -oxytocin. Synthesis and uterotonic activity.
    Bańkowski K
    Pol J Pharmacol Pharm; 1988; 40(3):331-5. PubMed ID: 2853867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postpartum uterine response to oxytocin and carbetocin.
    Amsalem H; Aldrich CJ; Oskamp M; Windrim R; Farine D
    J Reprod Med; 2014; 59(3-4):167-73. PubMed ID: 24724226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
    Smith CW; Botos CR; Skala G; Walter R
    J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and some pharmacological properties of two new antagonists of oxytocin.
    Rekowski P; Melin P; Lammek B
    Pol J Pharmacol Pharm; 1987; 39(3):303-7. PubMed ID: 3438212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO; Ferger MF
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and bioassay.
    Fric I; Hlavacek J; Rockway TW; Chan WY; Hruby VJ
    J Protein Chem; 1990 Feb; 9(1):9-15. PubMed ID: 2340080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of the third amino acid residue of oxytocin for its action on isolated rat uterus: study of relationship between hormone conformation and activity.
    Walter R; Smith CW; Roy J
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3054-8. PubMed ID: 184456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic substitution of an oxytocin antagonist with D-amino acids: unexpected high antagonistic potency of the D-Cys6-substituted analogue.
    Flouret G; Majewski T; Brieher W; Wilson L
    J Med Chem; 1993 Mar; 36(6):747-9. PubMed ID: 8459401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (2,4-Dileucine)exytocin. A polypeptide with natrituretic and diuretic activities, and an inhibitor of the oxytocic response of oxytocin.
    Hruby VJ; Chan WY
    J Med Chem; 1971 Nov; 14(11):1050-1. PubMed ID: 5115201
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-response behavior on the isolated rat uterus of oxytocin analogs with modifications at binding sites.
    Smith CW; Chan S; Walter R
    J Pharmacol Exp Ther; 1977 Oct; 203(1):120-4. PubMed ID: 909047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxytocin and its analogs, methyl-substituted in ortho-, meta- or para-position of aromatic ring of phenylalanine in position 2: NMR study and biological activities.
    Budesínsky M; Procházka Z; Slaninová J
    Protein Pept Lett; 2005 May; 12(4):343-7. PubMed ID: 15907179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxytocin antagonists with changes in the Asn5 position shed light on hormone-oxytocin receptor interactions.
    Hill PS; Chan WY; Hruby VJ
    Int J Pept Protein Res; 1991 Jul; 38(1):32-7. PubMed ID: 1657804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the uterotonic action of oxytocin and prostaglandins: oxytocin action and release of PG-activity in isolated nonpregnant and pregnant rat uteri.
    Chan WY
    Biol Reprod; 1977 Nov; 17(4):541-8. PubMed ID: 922089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.